The international healthcare landscape is experiencing a transformative paradigm shift, propelled by groundbreaking advances in personalized medicine and cutting-edge therapeutic development. Leading this medical revolution is the remarkable progress of Antibody Drug Conjugates (ADCs)—highly engineered pharmaceutical constructs that masterfully integrate the precise targeting capabilities...